Published in J Pediatr on April 01, 1992
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol (2011) 1.70
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09
A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels. Clin Exp Nephrol (2011) 0.92
Association of Mutations in SLC12A1 Encoding the NKCC2 Cotransporter With Neonatal Primary Hyperparathyroidism. J Clin Endocrinol Metab (2016) 0.79
Pathophysiology and clinical presentations of salt-losing tubulopathies. Pediatr Nephrol (2015) 0.78
Phosphate homeostasis in Bartter syndrome: a case-control study. Pediatr Nephrol (2014) 0.78
Treatment of hyperprostaglandin E syndrome with indomethacin. J Pediatr (1993) 0.75
Effects of NSAIDs on Differentiation and Function of Human and Murine Osteoclasts - Crucial 'Human Osteoclastology'. Pharmaceuticals (Basel) (2010) 0.75
Prostaglandin-E2 Mediated Increase in Calcium and Phosphate Excretion in a Mouse Model of Distal Nephron Salt Wasting. PLoS One (2016) 0.75
Accentuated hyperparathyroidism in type II Bartter syndrome. Pediatr Nephrol (2016) 0.75
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Direct text entry in electronic progress notes. An evaluation of input errors. Methods Inf Med (2003) 4.00
Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med (2001) 2.89
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod (2002) 2.55
Expression profiling of the maize flavonoid pathway genes controlled by estradiol-inducible transcription factors CRC and P. Plant Cell (2000) 2.17
Prenatal and postnatal management of hyperprostaglandin E syndrome after genetic diagnosis from amniocytes. Pediatrics (1999) 1.83
Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol (2001) 1.73
Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis (1992) 1.71
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 12. 1,2-Dihydroquinolylmethyl analogues with high activity and specificity for bacterial dihydrofolate reductase. J Med Chem (1989) 1.64
High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr (1992) 1.64
Mapping the main immunogenic region and toxin-binding site of the nicotinic acetylcholine receptor. Science (1987) 1.57
Milia-like idiopathic calcinosis cutis. Pediatr Dermatol (2004) 1.57
Neonatal opiate withdrawal and rooming-in: a retrospective analysis of a single center experience. Klin Padiatr (2013) 1.57
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
[Acquired peeling skin syndrome in an adult]. Ann Dermatol Venereol (2000) 1.51
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. J Clin Oncol (1997) 1.49
Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate. Toxicon (1972) 1.49
Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet (1994) 1.48
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47
Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin Padiatr (2011) 1.46
Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol (1997) 1.45
[Prevalence and management of chronic wounds in 14 geriatric institutions of the Haut-Rhin]. Ann Dermatol Venereol (2007) 1.43
Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis. J Clin Microbiol (1994) 1.41
Negative ion chemical ionization gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry of prostanoid pentafluorobenzyl ester/methoxime/trimethylsilyl ether derivatives. Biomed Environ Mass Spectrom (1988) 1.35
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res (2000) 1.27
Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene. Eur J Hum Genet (2000) 1.27
Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide. Chirality (1995) 1.25
Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr (1985) 1.17
Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res (1999) 1.15
Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: A Hoosier Oncology Group and Fox Chase Network phase III trial. J Clin Oncol (1999) 1.13
Factors influencing apnea and bradycardia of prematurity - implications for neurodevelopment. Neonatology (2006) 1.11
Misuse of metered-dose inhalers in hospitalized patients. Chest (1994) 1.09
Laryngo-tracheo-oesophageal cleft. Clinical features, diagnosis and therapy. Eur J Pediatr (1983) 1.09
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09
Mutations in the ROMK gene in antenatal Bartter syndrome are associated with impaired K+ channel function. Biochem Biophys Res Commun (1997) 1.07
Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur J Pediatr (1996) 1.07
Endpoints of resuscitation of critically injured patients: normal or supranormal? A prospective randomized trial. Ann Surg (2000) 1.06
Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. BMJ (1988) 1.05
2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 5. 3',5'-Dimethoxy-4'-substituted-benzyl analogues of trimethoprim. J Med Chem (1981) 1.05
The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg (1996) 1.04
The use of the double-balloon enteroscope for endoscopic retrograde cholangiopancreatography and biliary stent placement after Roux-en-Y hepaticojejunostomy. Endoscopy (2007) 1.03
REM sleep and NREM sleep in narcolepsy and hypersomnia. Electroencephalogr Clin Neurophysiol (1969) 1.03
Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics (2001) 1.02
2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes. J Med Chem (1987) 1.01
Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. Eur J Clin Pharmacol (1994) 1.00
[Treatment tactics and late results in early infection following osteosynthesis]. Unfallchirurgie (1986) 0.99
Generation of the isoprostane 8-epi-prostaglandin F2alpha in vitro and in vivo via the cyclooxygenases. J Pharmacol Exp Ther (1997) 0.99
Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis. Clin Pharmacol Ther (1975) 0.99
Phospholipid specificity of bovine heart bc1 complex. Eur J Biochem (1990) 0.99
Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit. J Biol Chem (1988) 0.99
Role of atrial natriuretic peptide in sodium homeostasis in premature infants. J Pediatr (1986) 0.99
Participation of the central nervous system in decompression. Ind Med Surg (1966) 0.99
Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization. DNA Cell Biol (2000) 0.98
Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies. Prostaglandins (1976) 0.98
Molecular features affecting the potency of tricyclic antidepressants and structurally related compounds as inhibitors of the uptake of tritiated norepinephrine by rabbit aortic strips. J Pharmacol Exp Ther (1969) 0.98
Some pyrimidines of biological and medicinal interest. 3. Prog Med Chem (1971) 0.97
Immunolocalization of the four prostaglandin E2 receptor proteins EP1, EP2, EP3, and EP4 in human kidney. J Am Soc Nephrol (1999) 0.97
Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol (2004) 0.97
Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit. Prostaglandins (1977) 0.97
Severe primary cutaneous aspergillosis refractory to amphotericin B and the successful treatment with systemic voriconazole in two premature infants with extremely low birth weight. J Perinatol (2006) 0.96
Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. J Pediatr (1983) 0.96
Hydroxylated metabolites of thalidomide: formation in-vitro and in-vivo in man. J Pharm Pharmacol (1998) 0.96
A quantitative polygraphic study of daytime somnolence and sleep in patients with excessive diurnal sleepiness. Schweiz Arch Neurol Neurochir Psychiatr (1984) 0.96
Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol (1997) 0.96
Pharmacotyping of hypokalaemic salt-losing tubular disorders. Acta Physiol Scand (2004) 0.95
Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr (2010) 0.95
Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. J Chromatogr (1994) 0.95
Acute hibernation decreases myocardial pyruvate carboxylation and citrate release. Am J Physiol Heart Circ Physiol (2001) 0.95
Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia. AJNR Am J Neuroradiol (1993) 0.95
Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids (1996) 0.94
Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro. Nature (1977) 0.94
Primary gene structure and expression studies of rodent paracellin-1. J Am Soc Nephrol (2001) 0.94
Synthesis and metabolism of endogenous prostaglandins by human gastric mucosa. Adv Prostaglandin Thromboxane Res (1980) 0.94
[Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee]. Z Rheumatol (2000) 0.92
Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects. Acta Paediatr (2009) 0.92
Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci (1981) 0.92
Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. Kidney Int (1987) 0.92
Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia (1986) 0.92
Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur J Pediatr (1991) 0.92
Recent progress in the medicinal chemistry of 2,4-diaminopyrimidines. Prog Med Chem (1982) 0.92
Neonatal haemochromatosis: report of a patient with favourable outcome. Eur J Pediatr (1997) 0.91
Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus. Eur J Pediatr (1983) 0.91
Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatory drugs. Bone (1999) 0.91
Intestinal perforation associated with indomethacin treatment in premature infants. Eur J Pediatr (1985) 0.91
Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis. Blood (1998) 0.91
Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants. Genes Immun (2006) 0.91
Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation? J Inherit Metab Dis (1997) 0.91
Oxalate, citrate, and sulfate concentration in human milk compared with formula preparations: influence on urinary anion excretion. J Pediatr Gastroenterol Nutr (1998) 0.91
Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol (1995) 0.90
Hypersomnia with "sleep drunkenness". Arch Gen Psychiatry (1972) 0.90
Protonated state of methotrexate, trimethoprim, and pyrimethamine bound to dihydrofolate reductase. Arch Biochem Biophys (1983) 0.90
Kleine-Levin syndrome ethiopathogenesis and treatment. Acta Univ Carol Med Monogr (1988) 0.90
Marked reduction of Tamm-Horsfall protein synthesis in hyperprostaglandin E-syndrome. Kidney Int (1993) 0.89
Atrial natriuretic peptide and patent ductus arteriosus in preterm infants. Arch Dis Child (1987) 0.89
DR2-negative narcolepsy. Lancet (1986) 0.89